Approval · Notice of Compliance 13087 · 2012
JAMP-MYCOPHENOLATE: Notice of Compliance 13087
Issued March 7, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13087
- Date
- March 7, 2012
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Immunosuppressive Agent
- Canadian reference product
- CELLCEPT (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP-MYCOPHENOLATE | 02380382 | Marketed |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB